SCHEMBL3609220

SCHEMBL3609220

COc1ccc(C(c2ccccc2)(c2ccc(C(=O)ON3C(=O)CCC3=O)cc2)C(O)CCO)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.39
ATM Q13315 1/20 0.39
KIF11 P52732 4/20 0.39
POLB P06746 2/20 0.38
MAPT P10636 2/20 0.38
MEN1 O00255 2/20 0.37
LMNA P02545 1/20 0.36
CYP2D6 P10635 2/20 0.36
SLC6A1 P30531 2/20 0.36
SLC6A11 P48066 1/20 0.36
GAA P10253 1/20 0.36
HDAC3 O15379 1/20 0.36
HDAC4 P56524 1/20 0.36
HDAC1 Q13547 1/20 0.36
HDAC7 Q8WUI4 1/20 0.36
HDAC2 Q92769 1/20 0.36
HDAC10 Q969S8 1/20 0.36
HDAC11 Q96DB2 1/20 0.36
HDAC8 Q9BY41 1/20 0.36
HDAC6 Q9UBN7 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3605593 0.83 NAMPT (0.39) POLBCYP2D6HDAC3HDAC1HDAC8
SCHEMBL14022988 0.82 POLB (0.44) KMT2AATMPOLBMAPTMEN1
SCHEMBL8824305 0.82 POLB (0.44) KMT2AATMPOLBMAPTMEN1
SCHEMBL3612061 0.81 POLB (0.43) KMT2AATMPOLBMAPTMEN1
SCHEMBL13939462 0.81 POLB (0.43) KMT2AATMPOLBMAPTMEN1
SCHEMBL8403280 0.80 KIF11 (0.48) KMT2AKIF11MEN1LMNA
SCHEMBL12340292 0.80 SLC6A11 (0.44) KMT2AATMPOLBMEN1SLC6A1
SCHEMBL3613077 0.78 NPC1 (0.41) MAPTCYP2D6HDAC1HDAC8NPC1
SCHEMBL7740161 0.78 CA1 (0.55) KMT2AATMPOLBMAPTMEN1
SCHEMBL13964486 0.77 POLB (0.41) KMT2AATMKIF11POLBMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7741044-B2 Libraries of oligomers labeled with different tags OXFORD GENE TECHNOLOGY IP LIMITED 2010-06-22 US disclosed
US-20090029866-A1 Libraries of oligomers labeled with different tags OXFORD GENE TECHNOLOGY IP LIMITED 2009-01-29 US disclosed
US-7399846-B2 Libraries of oligomers labeled with different tags OXFORD GENE TECHNOLOGY IP LIMITED (GB) 2008-07-15 US disclosed
US-20050003408-A1 Libraries of oligomers labeled with different tags ISIS INNOVATION LIMITED (GB) 2005-01-06 US disclosed
EP-1428810-A2 Libraries of oligomers labelled with different tags Oxford Gene Technology IP Limited (GB) 2004-06-16 EP disclosed
EP-1068216-B1 LIBRARIES OF OLIGOMERS LABELLED WITH DIFFERENT TAGS ISIS INNOVATION (GB) 2003-12-10 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090029866-A1 Libraries of oligomers labeled with different tags FBL, HNRNPL, MTREX KMT2A 2143/4885ATM 2491/4885KIF11 2201/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.